All Stories

  1. Vascular events in autoantibody-defined clusters of systemic lupus erythematosus: a 12-year prospective cohort study

    Article • Rheumatology, February 2026, Oxford University Press (OUP)

    Elizabeth Arkema

  2. Associations between social determinants of health and long-term outcomes in systemic lupus erythematosus: a nationwide population-based cohort study in Sweden

    Article • RMD Open, January 2026, BMJ

    Elizabeth Arkema

  3. Dietary patterns and lupus—a new piece in an unfinished puzzle

    Article • Rheumatology, October 2025, Oxford University Press (OUP)

    Elizabeth Arkema

  4. Risk of ischaemic and non-ischaemic heart failure in patients with systemic sclerosis: a population-based study

    Article • Rheumatology, August 2025, Oxford University Press (OUP)

    Elizabeth Arkema

  5. Thiopurines and Intrahepatic Cholestasis of Pregnancy in Systemic Lupus Erythematosus and Inflammatory Bowel Disease Pregnancies

    Article • The American Journal of Gastroenterology, July 2025, Wolters Kluwer Health

    Elizabeth Arkema

  6. Smoking and the risk of sarcoidosis: a systematic review and meta-analysis

    Article • Respiratory Medicine, May 2025, Elsevier

    Elizabeth Arkema

  7. Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden

    Article • Rheumatology, April 2025, Oxford University Press (OUP)

    Elizabeth Arkema

  8. Sarcoidosis Treatment Patterns in the United States

    Article • CHEST Journal, April 2025, Elsevier

    Elizabeth Arkema

  9. GWAS identifies genetic loci, lifestyle factors and circulating biomarkers that are risk factors for sarcoidosis

    Article • Nature Communications, March 2025, Springer Science + Business Media

    Elizabeth Arkema

  10. Development and evaluation of a Register-Based Organ Damage Index in systemic lupus erythematosus: a nationwide, population-based study from Sweden

    Article • Lupus Science & Medicine, February 2025, BMJ

    Elizabeth Arkema

  11. Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

    Article • Rheumatology, January 2025, Oxford University Press (OUP)

    Elizabeth Arkema

  12. Comorbid psoriasis in systemic lupus erythematosus: a cohort study from a tertiary referral centre and the National Patient Register in Sweden

    Article • Lupus Science & Medicine, January 2025, BMJ

    Elizabeth Arkema

  13. Response

    Article • CHEST Journal, January 2025, Elsevier

    Elizabeth Arkema

  14. Association between maternal systemic lupus erythematosus and infant infection: a population-based cohort study in Sweden

    Article • BMJ Open, December 2024, BMJ

    Elizabeth Arkema

  15. History and Familial Aggregation of Immune-Mediated Diseases in Sarcoidosis

    Article • CHEST Journal, November 2024, Elsevier

    Elizabeth Arkema

  16. Predicting the risk of pulmonary deterioration in sarcoidosis

    Article • Thorax, October 2024, BMJ

    Elizabeth Arkema

  17. Inflammatory plasma protein levels are elevated years before sarcoidosis diagnosis: a nested case–control study in Sweden

    Article • European Respiratory Journal, September 2024, European Respiratory Society (ERS)

    Elizabeth Arkema

  18. Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness

    Article • Lupus, August 2024, SAGE Publications

    Elizabeth Arkema

  19. Sick leave and disability pension following delivery in women with systemic lupus erythematosus

    Article • Scandinavian Journal of Rheumatology, April 2024, Taylor & Francis

    Elizabeth Arkema

  20. Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey

    Article • Lupus, March 2024, SAGE Publications

    Elizabeth Arkema

  21. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case–control study in Sweden

    Article • European Journal of Epidemiology, January 2024, Springer Science + Business Media

    Elizabeth Arkema

  22. Sarcoidosis and its relation to other immune-mediated diseases: Epidemiological insights

    Article • Journal of Autoimmunity, October 2023, Elsevier

    Elizabeth Arkema

  23. “The chameleon among diseases” - an explorative view of sarcoidosis and identification of the consequences for affected patients and relatives using qualitative interviews

    Article • Orphanet Journal of Rare Diseases, September 2023, Springer Science + Business Media

    Elizabeth Arkema

  24. Epidemiology and Damage Accrual of Systemic Lupus Erythematosus in Central Sweden: A Single‐Center Population‐Based Cohort Study Over 14 Years From Östergötland County

    Article • ACR Open Rheumatology, July 2023, Wiley

    Elizabeth Arkema

  25. Rheumatoid arthritis and the risk of postpartum psychiatric disorders: a Nordic population-based cohort study

    Article • BMC Medicine, April 2023, Springer Science + Business Media

    Elizabeth Arkema

  26. Sarcoidosis: Epidemiology and clinical insights

    Article • Journal of Internal Medicine, March 2023, Wiley

    Elizabeth Arkema

  27. Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

    Article • RMD Open, February 2023, BMJ

    Benedicte Delcoigne, Elizabeth Arkema

  28. Modifiable lifestyle risk factors for sarcoidosis: a nested case–control study

    Article • ERJ Open Research, January 2023, European Respiratory Society (ERS)

    Elizabeth Arkema

  29. Risk of gestational diabetes mellitus in relation to early pregnancy and gestational weight gain before diagnosis: A population‐based cohort study

    Article • Acta Obstetricia Et Gynecologica Scandinavica, September 2022, Wiley

    Elizabeth Arkema

  30. Direct modeling of relative and absolute risks in register data: Mortality risk in sarcoidosis

    Article • Annals of Epidemiology, February 2022, Elsevier

    Elizabeth Arkema

  31. Reproductive and hormonal risk factors for sarcoidosis: a nested case–control study

    Article • BMC Pulmonary Medicine, January 2022, Springer Science + Business Media

    Elizabeth Arkema

  32. Differences in disease presentation between men and women with sarcoidosis: A cohort study

    Article • Respiratory Medicine, January 2022, Elsevier

    Elizabeth Arkema

  33. Gestational Diabetes Mellitus Risk in Pregnant Women With Systemic Lupus Erythematosus

    Article • The Journal of Rheumatology, December 2021, The Journal of Rheumatology

    Elizabeth Arkema

  34. Risk of acute myocardial infarction in sarcoidosis: A population-based cohort study from Sweden

    Article • Respiratory Medicine, November 2021, Elsevier

    Elizabeth Arkema

  35. Infection hospitalisation in systemic lupus in Sweden

    Article • Lupus Science & Medicine, September 2021, BMJ

    Elizabeth Arkema

  36. Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden

    Article • Heart, May 2021, BMJ

    Elizabeth Arkema

  37. Evidence of under‐reporting of early‐onset preeclampsia using register data

    Article • Paediatric and Perinatal Epidemiology, May 2021, Wiley

    Elizabeth Arkema

  38. Type 2 diabetes risk in sarcoidosis patients untreated and treated with corticosteroids

    Article • ERJ Open Research, April 2021, European Respiratory Society (ERS)

    Joshua Entrop, Elizabeth Arkema

  39. Tuberculosis in Biologic-naïve Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics

    Article • The Journal of Rheumatology, April 2021, The Journal of Rheumatology

    Elizabeth Arkema

  40. Maternal Hypertensive Disorders in Pregnant Women With Systemic Lupus Erythematosus and Future Cardiovascular Outcomes

    Article • Arthritis Care & Research, March 2021, Wiley

    Elizabeth Arkema

  41. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis

    Article • Rheumatology, February 2021, Oxford University Press (OUP)

    Elizabeth Arkema

  42. Positive Predictive Value of Sarcoidosis Identified in an Administrative Healthcare Registry: A Validation Study

    Article • Epidemiology, January 2021, Wolters Kluwer Health

    Elizabeth Arkema

  43. Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real‐world data

    Article • Respirology, January 2021, Wiley

    Elizabeth Arkema

  44. Maternal and infant outcomes in sarcoidosis pregnancy: a Swedish population-based cohort study of first births

    Article • August 2020, Springer Science + Business Media

    Elizabeth Arkema

  45. Gestational weight gain and delivery outcomes: A population‐based cohort study

    Article • Paediatric and Perinatal Epidemiology, July 2020, Wiley

    Elizabeth Arkema

  46. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors

    Article • Current Opinion in Pulmonary Medicine, July 2020, Wolters Kluwer Health

    Elizabeth Arkema

  47. Response to: ‘Neuroinflammatory events after anti-TNFα therapy’ by Kaltsonoudiset al

    Article • Annals of the Rheumatic Diseases, May 2020, BMJ

    Benedicte Delcoigne, Elizabeth Arkema

  48. Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    Dr Marios Rossides, Elizabeth Arkema

  49. Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden

    Article • Annals of the Rheumatic Diseases, March 2020, BMJ

    Benedicte Delcoigne, Elizabeth Arkema

  50. Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case–control study

    Article • European Journal of Epidemiology, February 2020, Springer Science + Business Media

    Elizabeth Arkema

  51. Sarcoidosis diagnosis and treatment in Sweden: A register-based assessment of variations by region and calendar period

    Article • Respiratory Medicine, January 2020, Elsevier

    Elizabeth Arkema

  52. Sarcoidosis

    Article • Nature Reviews Disease Primers, July 2019, Springer Science + Business Media

    Elizabeth Arkema

  53. The Risk of Ischemic and Hemorrhagic Stroke in Patients With Idiopathic Inflammatory Myopathies: A Swedish Population‐Based Cohort Study

    Article • Arthritis Care & Research, June 2019, Wiley

    Elizabeth Arkema

  54. Correspondence for “Clinical epidemiology of familial sarcoidosis: A systematic literature review”

    Article • Respiratory Medicine, May 2019, Elsevier

    Dr Marios Rossides, Elizabeth Arkema

  55. Infections increase the risk of developing Sjögren's syndrome

    Article • Journal of Internal Medicine, April 2019, Wiley

    Elizabeth Arkema

  56. Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

    Article • Annals of the Rheumatic Diseases, January 2019, BMJ

    Elizabeth Arkema

  57. Work ability before and after sarcoidosis diagnosis in Sweden

    Article • Respiratory Medicine, November 2018, Elsevier

    Elizabeth Arkema

  58. Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study

    Article • Arthritis Care & Research, September 2018, Wiley

    MD, PhD Jerker Jonsson, Elizabeth Arkema

  59. Epidemiology of sarcoidosis: current findings and future directions

    Article • Therapeutic Advances in Chronic Disease, August 2018, SAGE Publications

    Elizabeth Arkema

  60. Children born to mothers with lupus are at a higher risk for childhood asthma

    Article • Arthritis Care & Research, July 2018, Wiley

    Dr Marios Rossides, Elizabeth Arkema

  61. Dr. Rossides, et al reply

    Article • The Journal of Rheumatology, July 2018, The Journal of Rheumatology

    Dr Marios Rossides, Elizabeth Arkema

  62. Sarcoidosis: Family history is a very strong risk factor – 39% of disease risk due to genetics

    Article • European Respiratory Journal, June 2018, European Respiratory Society (ERS)

    Dr Marios Rossides, Elizabeth Arkema

  63. Childhood death rates declined in Sweden from 2000 to 2014 but deaths from external causes were not always investigated

    Article • Acta Paediatrica, April 2018, Wiley

    Elizabeth Arkema

  64. Mortality is low for the majority of individuals with sarcoidosis

    Article • European Respiratory Journal, February 2018, European Respiratory Society (ERS)

    Dr Marios Rossides, Elizabeth Arkema

  65. Response to: ‘Increased stroke incidence in systemic lupus erythematosus patients: risk factors or disease itself?’ by Bruzzese and Zullo

    Article • Annals of the Rheumatic Diseases, November 2017, BMJ

    Dr Marios Rossides, Elizabeth Arkema

  66. Higher mortality and lower functionality after stroke for patients with systemic lupus erythematosus

    Article • The Journal of Rheumatology, September 2017, The Journal of Rheumatology

    Dr Marios Rossides, Elizabeth Arkema

  67. Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case–control study

    Article • Annals of the Rheumatic Diseases, August 2017, BMJ

    Elizabeth Arkema

  68. Elevated BMI and antibodies to citrullinated proteins interact to increase rheumatoid arthritis risk and shorten time to diagnosis: A nested case–control study of women in the Nursesʼ Health Studies

    Article • Seminars in Arthritis and Rheumatism, June 2017, Elsevier

    Elizabeth Arkema

  69. Stroke in systemic lupus erythematosus: a Swedish population-based cohort study

    Article • Annals of the Rheumatic Diseases, April 2017, BMJ

    Elizabeth Arkema

  70. Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study

    Article • Rheumatology, February 2017, Oxford University Press (OUP)

    Elizabeth Arkema

  71. Cervical neoplasia in systemic lupus erythematosus: a nationwide study

    Article • Rheumatology, December 2016, Oxford University Press (OUP)

    Elizabeth Arkema

  72. Medication use among pregnant women with systemic lupus erythematosus and general population comparators

    Article • Rheumatology, December 2016, Oxford University Press (OUP)

    Elizabeth Arkema

  73. Early-onset Preeclampsia in Lupus Pregnancy

    Article • Paediatric and Perinatal Epidemiology, December 2016, Wiley

    Elizabeth Arkema

  74. Brief Report: Sex Ratio of Offspring Born to Women With Systemic Lupus Erythematosus or Rheumatoid Arthritis

    Article • Arthritis & Rheumatology, December 2016, Wiley

    Elizabeth Arkema

  75. Induction maintenance with tumour necrosis factor-inhibitor combination therapy with discontinuation versus methotrexate monotherapy in early rheumatoid arthritis: a systematic review and meta-analysis of efficacy in randomised controlled trials

    Article • RMD Open, September 2016, BMJ

    Elizabeth Arkema

  76. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden

    Article • European Respiratory Journal, July 2016, European Respiratory Society (ERS)

    Elizabeth Arkema

  77. What to Expect When Expecting With Systemic Lupus Erythematosus (SLE): A Population‐Based Study of Maternal and Fetal Outcomes in SLE and Pre‐SLE

    Article • Arthritis Care & Research, June 2016, Wiley

    Elizabeth Arkema

  78. Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

    Article • Annals of the Rheumatic Diseases, May 2016, BMJ

    Elizabeth Arkema

  79. Endometriosis and systemic lupus erythematosus: a population-based case–control study

    Article • Lupus, February 2016, SAGE Publications

    Elizabeth Arkema

  80. Case definitions in Swedish register data to identify systemic lupus erythematosus

    Article • BMJ Open, January 2016, BMJ

    Elizabeth Arkema

  81. Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies

    Article • RMD Open, December 2015, BMJ

    Elizabeth Arkema

  82. Cohort profile: systemic lupus erythematosus in Sweden: the Swedish Lupus Linkage (SLINK) cohort: Figure 1

    Article • BMJ Open, August 2015, BMJ

    Elizabeth Arkema

  83. Monocyte chemotactic protein-1 elevation prior to the onset of rheumatoid arthritis among women

    Article • Biomarkers in Medicine, August 2015, Future Medicine

    Elizabeth Arkema

  84. Perinatal risk factors for future SLE: a population-based nested case-control study

    Article • Lupus, February 2015, SAGE Publications

    Elizabeth Arkema

  85. No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment

    Article • Annals of the Rheumatic Diseases, August 2014, BMJ

    Elizabeth Arkema

  86. Circulating 25-hydroxyvitamin D level and risk of developing rheumatoid arthritis

    Article • Rheumatology, July 2014, Oxford University Press (OUP)

    Elizabeth Arkema

  87. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study

    Article • Annals of the Rheumatic Diseases, July 2014, BMJ

    Elizabeth Arkema

  88. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

    Article • Annals of the Rheumatic Diseases, March 2014, BMJ

    MD, PhD Jerker Jonsson, Elizabeth Arkema

  89. Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab

    Article • Annals of the Rheumatic Diseases, November 2013, BMJ

    Elizabeth Arkema

  90. Patients With Ulcerative Colitis Miss More Days of Work Than the General Population, Even Following Colectomy

    Article • Gastroenterology, March 2013, Elsevier

    Elizabeth Arkema

  91. Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses’ Health Study

    Article • Annals of the Rheumatic Diseases, February 2013, BMJ

    Elizabeth Arkema

  92. Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case–control study

    Article • Arthritis Research & Therapy, January 2013, Springer Science + Business Media

    Elizabeth Arkema

  93. Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study

    Article • Annals of the Rheumatic Diseases, June 2012, BMJ

    Elizabeth Arkema

  94. Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study

    Article • Annals of the Rheumatic Diseases, April 2012, BMJ

    Elizabeth Arkema

  95. Ten years with biologics: to whom do data on effectiveness and safety apply?

    Article • Rheumatology, November 2010, Oxford University Press (OUP)

    Elizabeth Arkema

  96. Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers

    Article • Rheumatology, September 2010, Oxford University Press (OUP)

    Elizabeth Arkema

  97. A Prospective Study of Periodontal Disease and Risk of Rheumatoid Arthritis

    Article • The Journal of Rheumatology, July 2010, The Journal of Rheumatology

    Elizabeth Arkema

  98. Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission

    Article • Annals of the Rheumatic Diseases, April 2010, BMJ

    Elizabeth Arkema